Embase and PubMed were systematically searched for articles addressing the neuroprotective properties of phytocannabinoids, apart from cannabidiol and Δ -tetrahydrocannabinol, including Δ -tetrahydrocannabinolic acid, Δ -tetrahydrocannabivarin, cannabidiolic acid, cannabidivarin, cannabichromene, cannabichromenic acid, cannabichromevarin, cannabigerol, cannabigerolic acid, cannabigerivarin, cannabigerovarinic acid, cannabichromevarinic acid, cannabidivarinic acid, and cannabinol. Out of 2,341 studies, 31 articles met inclusion criteria. Cannabigerol (range 5 to 20 mg·kg ) and cannabidivarin (range 0.2 to 400 mg·kg ) displayed efficacy in models of Huntington's disease and epilepsy. Cannabichromene (10-75 mg·kg ), Δ -tetrahydrocannabinolic acid (20 mg·kg ), and tetrahydrocannabivarin (range 0.025-2.5 mg·kg ) showed promise in models of seizure and hypomobility, Huntington's and Parkinson's disease. Limited mechanistic data showed cannabigerol, its derivatives VCE.003 and VCE.003.2, and Δ -tetrahydrocannabinolic acid mediated some of their effects through PPAR-γ, but no other receptors were probed. Further studies with these phytocannabinoids, and their combinations, are warranted across a range of neurodegenerative disorders.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484504 | PMC |
| http://dx.doi.org/10.1111/bph.15185 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
High-Performance Liquid Chromatography with DAD Detection for the Determination of Cannabinoids in Commercial Veterinary CBD Oil.
Pharmacy (Basel)
December 2024
Faculty of Veterinary Medicine-Skopje, University "Ss. Cyril and Methodius", Lazar Pop-Trajkov 5/7, 1000 Skopje, North Macedonia.
The study highlights the need for quality control in evaluating medicinal plant products, especially CBD oils, before market release. Due to varying regulatory requirements, product labeling can sometimes be misleading, especially regarding cannabinoid concentrations such as CBD and THC. This research focused on developing a validated high-performance liquid chromatography (HPLC) method for accurately identifying and quantifying key cannabinoids in Commercial Veterinary CBD Oil.
View Article and Find Full Text PDFUnique bibenzyl cannabinoids in the liverwort Radula marginata: parallels with Cannabis chemistry.
New Phytol
December 2024
PFR, Chemistry Department, University of Otago, Dunedin, 9016, New Zealand.
The potential of cannabinoids to address public health challenges has stimulated exploration into alternative sources and production technologies. Radula marginata, an endemic Aotearoa/New Zealand liverwort, produces the bibenzyl cannabinoid perrottetinene (PET), analogous to Cannabis psychoactive tetrahydrocannabinol (THC). Structural differences between PET and THC could alter therapeutic interactions and mitigate adverse side effects.
View Article and Find Full Text PDFEngineering for production of active cannabinoid synthases via secretory pathway optimization.
Biotechnol Rep (Amst)
March 2025
Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
The production of cannabinoid compounds such as Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD) and cannabichromene (CBC) with potential pharmaceutical applications is growing sharply. However, challenges such as the low yield of minor cannabinoids, legal restrictions on cultivation, and the complexity and cost of purification from the Cannabis sativa plant necessitate a biotechnological approach. Since the biosynthetic pathway is disclosed, cannabinoids have been produced in yeast, insect cells and plants mainly by the heterologous expression of tetrahydrocannabinol acid synthase (THCAS).
View Article and Find Full Text PDFFatty acid binding protein 7 plays an important modulatory sex-dependent role on brain endocannabinoid levels and THC metabolism.
PLoS One
December 2024
Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, State University of New York at Buffalo, Buffalo, NY, United States of America.
Article Synopsis
- FABP7 is a protein found in the brain that may help transport cannabinoids like THC, but its role in the endocannabinoid system is not fully understood.
- In a study using mice lacking FABP7, researchers measured THC and its metabolite 11-OH-THC levels after THC inhalation, finding that females with FABP7 deletion had lower levels of 11-OH-THC compared to those with the protein.
- The study also revealed that FABP7 influences endocannabinoid levels, showing females with FABP7 deletion had decreased levels of anandamide and increased levels of 2-AG, indicating a sex-specific role in THC metabolism and endocannabinoid regulation.
Trema micranthum (L.) Blume as a new source of cannabinoids.
Sci Rep
November 2024
Department of Chemical Engineering, Military Institute of Engineering, Rio de Janeiro, RJ, Brazil.
Article Synopsis
- Trema micranthum, a plant from the Cannabaceae family, shows potential as a new source of cannabinoids like CBD, amid the regulatory issues surrounding Cannabis sativa due to THC content.
- This study used advanced UHPLC-HRMS/MS techniques to analyze different parts of the plant—fruits, leaves, inflorescences, and stems—for the presence of CBD, THC, and their acidic precursors (THCA A and CBDA).
- The results revealed significant levels of cannabinoids, especially in the leaves (4.43 µg/g CBD, 1.05 µg/g THC), indicating that Trema micranthum could serve as a viable alternative source for cannabinoid research and production.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!